Sale!
Sale!
Abetis 40mg
Original price was: 151.00 ৳ .149.49 ৳ Current price is: 149.49 ৳ .
ACI Pharmaceuticals.
Name Abetis
Generic Olmesartan medoxomi INN
Type Tablet
In stock (can be backordered)
Abetis 40mg
You must be logged in to post a review.
No more offers for this product!
Shipping Policy
Refund Policy
Cancellation / Return / Exchange Policy
General Inquiries
There are no inquiries yet.
Related Products
-
Restobac 10mg
Original price was: 80.00 ৳ .79.20 ৳ Current price is: 79.20 ৳ . -
Ivanor 5mg
Original price was: 250.00 ৳ .247.50 ৳ Current price is: 247.50 ৳ . -
Xpa 500mg
Original price was: 8.00 ৳ .7.92 ৳ Current price is: 7.92 ৳ . -
Etocox 90mg
Original price was: 91.00 ৳ .90.09 ৳ Current price is: 90.09 ৳ . -
Recur 1mg
Original price was: 41.00 ৳ .40.59 ৳ Current price is: 40.59 ৳ . -
Melcam 15mg
Original price was: 41.00 ৳ .40.59 ৳ Current price is: 40.59 ৳ . -
Clofenac 25mg
Original price was: 10.00 ৳ .9.90 ৳ Current price is: 9.90 ৳ . -
Anreb 50mg
Original price was: 80.00 ৳ .79.20 ৳ Current price is: 79.20 ৳ . -
Anfree 10mg
Original price was: 50.00 ৳ .45.50 ৳ Current price is: 45.50 ৳ . -
Ostel 10mg
Original price was: 51.00 ৳ .50.49 ৳ Current price is: 50.49 ৳ . -
Filwel Gold®30 tablet
Original price was: 285.00 ৳ .283.00 ৳ Current price is: 283.00 ৳ . -
Efigrel 10mg
Original price was: 200.00 ৳ .198.00 ৳ Current price is: 198.00 ৳ . -
Beclovan 10mg
Original price was: 80.00 ৳ .79.20 ৳ Current price is: 79.20 ৳ . -
Inflagic 5mg
Original price was: 12.00 ৳ .11.88 ৳ Current price is: 11.88 ৳ . -
Zomitan 2.5mg
Original price was: 250.00 ৳ .247.50 ৳ Current price is: 247.50 ৳ . -
Serelam 0.25mg
Original price was: 10.00 ৳ .9.90 ৳ Current price is: 9.90 ৳ . -
Tesod 6mg
Original price was: 51.00 ৳ .50.49 ৳ Current price is: 50.49 ৳ . -
Tino 50mg
Original price was: 40.00 ৳ .39.60 ৳ Current price is: 39.60 ৳ . -
Depram 25mg
Original price was: 40.00 ৳ .39.60 ৳ Current price is: 39.60 ৳ . -
Angilock 100mg
Original price was: 120.00 ৳ .118.80 ৳ Current price is: 118.80 ৳ .
Reviews
There are no reviews yet.